Residual risk of liver disease after hepatitis C virus eradication.

Negro, Francesco

Negro, Francesco.

Affiliation

Negro F; Divisions of Gastroenterology and hepatology, Geneva University Hospitals, Geneva, Switzerland; Divisions of Clinical pathology, Geneva University Hospitals, Geneva, Switzerland. Electronic address: Francesco.Negro@hcuge.ch.

J Hepatol ; 74(4): 952-963, 2021 04.

Article in En | MEDLINE | ID: mdl-33276027

Subject(s)

Hepatitis C, Chronic; Liver Diseases; Risk Assessment; Antiviral Agents/pharmacology; Hepatitis C, Chronic/complications; Hepatitis C, Chronic/drug therapy; Humans; Liver Diseases/classification; Liver Diseases/diagnosis; Liver Diseases/etiology; Sustained Virologic Response

Key words

Antivirals; Cirrhosis; Hepatocellular carcinoma; Liver-related mortality; Steatosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Risk Assessment / Hepatitis C, Chronic / Liver Diseases Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google